Bone mineral density fall during aromatase inhibitor treatment may predict lower breast cancer recurrence.

Published in: Cancer medicine (2024)

The findings suggest an association may exist between lumbar spine BMD change and breast cancer recurrence for patients treated with adjuvant AI. Further research is required to determine whether BMD change can be utilised as a biomarker.

Keyphrases

bone mineral density
postmenopausal women
body composition
free survival
early stage
artificial intelligence
machine learning
replacement therapy
breast cancer risk
deep learning